New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
May 30, 2014
16:34 EDTSHPG, BLOX, SPLK, NPSP, VRX, RTRX, LGF, AGNOn The Fly: Closing Wrap
The market began the session in quiet fashion and remained that way throughout the day. There was little for investors to get excited about, as the dayís economic data proved to be a mixed bag. The averages moved in a narrow range on very light volume while the news flow slowed to a trickle. With memorial Day kicking off the summer season and the week shortened by a day, investors appeared content to let the market drift in the last trading day of the week and the month, albeit near record levels. ECONOMIC EVENTS: In the U.S., personal income rose 0.3% in April, matching expectations, while consumer spending fell 0.1%, versus an expected increase of 0.2%. The Chicago ISM index rose 2.5 points to 65.5 in May, which was much better than expected. The final University of Michigan consumer confidence reading for May came in at 81.9, which was up just 0.1 from the prior reading and a hair below the expected 82.5 figure. COMPANY NEWS: Valeant Pharmaceuticals (VRX) raised its offer for Allergan (AGN) for the second time this week. Under the newly revised proposal, each Allergan share would be exchanged for $72.00 in cash and 0.83 shares of Valeant common stock, plus a Contingent Value Right for DARPin of up to $25.00 per share in value. This is up from the $58.30 in cash, plus shares and the CVR, that Valeant offered just two days ago. MAJOR MOVERS: Among the notable gainers was Retrophin (RTRX), which gained $1.74, or 13.51%, to $14.62 after announcing a license agreement with Mission Pharmacal for Thiola and revising its guidance. Also higher was NPS Pharmaceuticals (NPSP), which jumped $3.68, or 13.41%, to $31.13 after FT Alphaville, citing "usually well informed sources," said Shire (SHPG) has held internal discussions about a potential cash takeover offer for its smaller pharmaceutical industry peer. Among the noteworthy losers was Infoblox (BLOX), which plunged $7.56, or 36.84%, to $12.96 after the company's outlook for the new quarter missed expectations, its CEO Robert Thomas said he will step down and the shares were downgraded by at least six Street research firms. Other decliners following their earnings reports were data analysis software provider Splunk (SPLK), which fell $8.18, or 16.35%, to $41.86, and "Hunger Games" producer Lions Gate (LGF), which dropped $3.40, or 11.51%, to $26.13. INDEXES: The Dow was up 18.43, or 0.11%, to 16,717.17, the Nasdaq was down 5.33, or 0.13%, to 4,242.62, and the S&P 500 was up 3.54, or 0.18%, to 1,923.57.
News For AGN;VRX;BLOX;LGF;NPSP;SHPG;RTRX;SPLK From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
April 8, 2015
09:20 EDTLGFOn The Fly: Pre-market Movers
Subscribe for More Information
09:01 EDTLGFLionsgate 10M share Spot Secondary priced at $32.00
JPMorgan acted as sole book running manager for the offering.
08:01 EDTSPLKSplunk awarded contract to support Lockheed Martin's L-35 Lightning II Program
Splunk (SPLK) announced it was awarded a contract to support Lockheed Martinís (LMT) F-35 Lightning II Program. Splunk has provided Lockheed Martin with Splunk Enterprise to monitor and analyze IT systems and network behavior for the Autonomic Logistics Information System, which supports the F-35 Lightning II, a 5th generation fighter jet. Splunk Enterprise is initially being used by Lockheed Martin in 25 different operating environments for IT operations and application delivery, analyzing machine data from the systems and networks supporting the ALIS infrastructure to help ensure applications are operating at peak performance.
06:21 EDTLGFLionsgate 10M share Spot Secondary; price range $32.01-$33.00
The Lionsgate 10M shares Spot Secondary is being re-offered in the range of $32.01-$33.00 versus a $33.68 close. JPMorgan is acting as sole book running manager for the offering.
06:02 EDTLGFLionsgate should be bought on any weakness, says Piper Jaffray
Subscribe for More Information
April 7, 2015
19:10 EDTLGFOn The Fly: After Hours Movers
Subscribe for More Information
16:19 EDTLGFLionsgate says tracking at lower end of previous adjusted EBITDA guidance
Subscribe for More Information
16:05 EDTLGFLionsgate files to sell 10M shares of common stock for holders
JPMorgan is acting as sole book running manager for the offering.
10:43 EDTSPLKInformatica rises after agreeing to be taken private for $48.75 per share
Subscribe for More Information
10:10 EDTSHPGJazz patent on Xyrem latest to be challenged by Kyle Bass
Subscribe for More Information
10:05 EDTSPLKOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Carnival (CCL) upgraded to Outperform from Market Perform at Wells Fargo... Crown Castle (CCI) upgraded to Buy from Hold at Evercore ISI... Ctrip.com (CTRP) upgraded to Overweight from Neutral at Piper Jaffray... Demandware (DWRE) upgraded to Conviction Buy from Buy at Goldman... FirstEnergy (FE) upgraded at BofA/Merrill... Frontier Communications (FTR) upgraded to Neutral from Underperform at DA Davidson... JPMorgan (JPM) upgraded to Outperform from Market Perform at Bernstein... Pattern Energy (PEGI) upgraded to Outperform from Market Perform at Raymond James... Ralph Lauren (RL) upgraded to Buy from Outperform at CLSA... ResMed (RMD) upgraded to Outperform from Neutral at Credit Suisse... Ryanair (RYAAY) upgraded to Overweight from Neutral at JPMorgan... Splunk (SPLK) upgraded to Overweight from Neutral at Piper Jaffray... Total (TOT) upgraded at RBC Capital... Verifone (PAY) upgraded to Buy from Hold at Stifel... XL Group (XL) upgraded to Buy from Neutral at UBS.
08:10 EDTSHPGShire shares pricing in worst case scenario for patents, says Citigroup
Subscribe for More Information
07:13 EDTSHPGShire patent challenges only modest threat, says Jefferies
Subscribe for More Information
06:40 EDTSPLKSplunk upgraded to Overweight from Neutral at Piper Jaffray
Piper Jaffray analyst Katherine Egbert upgraded Splunk (SPLK) to Overweight saying the stock's valuation is more reasonable following the 13% sell-off since the company's Q4 earnings report. Egbert views Splunk's new distribution agreement with Arrow Electronics (ARW) as a sign of improving demand and she sees the potential for upsell of enterprise-wide license agreements. Shares of the provider of big data products closed yesterday up 95c to $60.18 after analysts at Stephens upgraded the stock Monday morning.
05:23 EDTSHPGShire reaches agreement with FDA on clear regulatory path for SHP465
Shire announces that it has reached an agreement with the FDA on a clear regulatory path for SHP465, an investigational oral stimulant medication being evaluated as a potential treatment for Attention-Deficit/Hyperactivity Disorder, or ADHD, in adults. Shire has agreed with the FDA to conduct a short-term efficacy and safety study in pediatric patients with ADHD. While Shire intends to pursue an adult indication, the FDA is requesting this additional pediatric data to better understand the potential effects of SHP465 on children with ADHD in the event of use in this population. The company anticipates the clinical trial's first patient, first visit to take place in August 2015, with study completion targeted by the last quarter of 2016. Shire then expects to submit to the FDA by 2Q17 a Class 2 resubmission for approval of SHP465 as a treatment for ADHD in adults, which typically entails a 6-month review. Pending FDA approval, Shire anticipates launching the medicine in the second half of 2017. This update follows Shire's announcement on October 9, 2014, that it was engaging the FDA to determine the parameters of clinical data requirements in order to submit the Class 2 resubmission.
April 6, 2015
10:33 EDTSPLKFollow-up: Splunk upgraded at Stephens
Subscribe for More Information
10:02 EDTSPLKOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:09 EDTSHPGShire says will defend patents 'vigorously' after Hayman petitions
Subscribe for More Information
07:15 EDTSPLKSplunk upgraded to Overweight from Equal Weight at Stephens
Subscribe for More Information
April 5, 2015
18:34 EDTLGFComcast's 'Furious 7' leads at weekend box office with $143.6M
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use